Keman Cheng
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Microbiology top 1%
- Bacterial Infections and Vaccines
Papers in
-
- Cancer Research and Treatments 9
- Immunology 20
- Immunotherapy and Immune Responses 15
- Co-authors
- Guangjun NieXiao ZhaoYao LiYinlong ZhangLei RenXuexiang HanGregory J. AndersonGuangna Liu
- Journals
- Advanced Materials (10 papers)Nature Communications (3 papers)ACS Nano (3 papers)Biomaterials (3 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Keman Cheng
50 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Biomaterials 860
- Microbiology 370
- Biotechnology 487
- Immunology 1.2k
- Biomedical Engineering 2.2k
Countries citing papers authored by Keman Cheng
This map shows the geographic impact of Keman Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keman Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keman Cheng more than expected).
Fields of papers citing papers by Keman Cheng
This network shows the impact of papers produced by Keman Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keman Cheng. The network helps show where Keman Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Keman Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 18 | |
| 7 | 2023 | 9 | |
| 8 | Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity Hit paper breakdown → | 2023 | 101 |
| 9 | 2023 | 47 | |
| 10 | 2022 | 67 | |
| 11 | Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines Hit paper breakdown → | 2021 | 186 |
| 12 | Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology Hit paper breakdown → | 2021 | 359 |
| 13 | 2021 | 29 | |
| 14 | Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy Hit paper breakdown → | 2019 | 356 |
| 15 | 2019 | 54 | |
| 16 | 2019 | 51 | |
| 17 | 2018 | 112 | |
| 18 | 2017 | 59 | |
| 19 | 2017 | 31 | |
| 20 | 2016 | 224 |
About Keman Cheng
Keman Cheng is a scholar working on Biotechnology, Immunology, Microbiology, Biomaterials and Biomedical Engineering, having authored 52 papers that have together received 4.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (19 papers), Immunotherapy and Immune Responses (15 papers), RNA Interference and Gene Delivery (9 papers), Cancer Research and Treatments (9 papers), Nanoparticle-Based Drug Delivery (8 papers), Extracellular vesicles in disease (6 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Biomaterials (860 citations), Microbiology (370 citations), Biotechnology (487 citations), Immunology (1.2k citations) and Biomedical Engineering (2.2k citations). Keman Cheng has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Guangjun Nie, Xiao Zhao, Yao Li, Yinlong Zhang, Lei Ren, Xuexiang Han, Gregory J. Anderson, Guangna Liu, Ruifang Zhao and Qingqing Feng. Their work appears in journals such as Advanced Materials, Nature Communications, ACS Nano, Biomaterials and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.